SUSAN KIMPER: Open Payments
NPI 1619602828 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,398 in 116 payments from 17 companies in 2025. Trend: 2023 $1,742 · 2024 $1,691 · 2025 $2,398
Food & beverage: $2,398
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 17 | $508 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 32 | $457 |
| ABBVIE INC. | 13 | $314 |
| E.R. Squibb & Sons, L.L.C. | 8 | $210 |
| Alkermes, Inc. | 13 | $206 |
| Lundbeck LLC | 9 | $173 |
| Vanda Pharmaceuticals Inc. | 4 | $112 |
| Collegium Pharmaceutical, Inc. | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Janssen Pharmaceuticals, Inc | 2 | $63 |
Products named: Auvelity, CAPLYTA, VRAYLAR, REXULTI, COBENFY, ARISTADA, Jornay PM, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
